CN102949303A - Emulsion composite - Google Patents
Emulsion composite Download PDFInfo
- Publication number
- CN102949303A CN102949303A CN2012102817499A CN201210281749A CN102949303A CN 102949303 A CN102949303 A CN 102949303A CN 2012102817499 A CN2012102817499 A CN 2012102817499A CN 201210281749 A CN201210281749 A CN 201210281749A CN 102949303 A CN102949303 A CN 102949303A
- Authority
- CN
- China
- Prior art keywords
- composition
- content
- component
- mass
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Cosmetics (AREA)
Abstract
本发明涉及一种乳化组合物,其含有以下成分(A)、(B)、(C)、(D)、(E)以及(F):(A)甘油单脂肪酸酯;(B)碳原子数为10~24的高级醇;(C)神经酰胺类;(D)阴离子表面活性剂;(E)选自(聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷)交联聚合物、(聚二甲基硅氧烷/苯基乙烯基聚二甲基硅氧烷)交联聚合物以及(乙烯基聚二甲基硅氧烷/月桂基聚二甲基硅氧烷)交联聚合物中的1种或者2种以上的交联型聚硅氧烷;(F)水,并且,成分(A)、(B)、(C)以及换算成酸的成分(D)的含量与成分(E)的含量的质量比例为((A)+(B)+(C)+(D))/(E)=1~125。The present invention relates to an emulsified composition, which contains the following components (A), (B), (C), (D), (E) and (F): (A) glycerol monofatty acid ester; (B) carbon Higher alcohols with 10~24 atoms; (C) ceramides; (D) anionic surfactants; (E) selected from (polydimethylsiloxane/vinyl polydimethylsiloxane) Crosspolymer, (Dimethicone/Phenyl Vinyl Dimethicone) Crosspolymer, and (Vinyl Dimethicone/Lauryl Dimethicone ) one or more cross-linked polysiloxanes among the cross-linked polymers; (F) water, and components (A), (B), and (C) and components (D) converted to acids The mass ratio of the content of the component (E) to the content of the component (E) is ((A)+(B)+(C)+(D))/(E)=1~125.
Description
技术领域 technical field
本发明涉及乳化组合物。The present invention relates to emulsified compositions.
背景技术 Background technique
α-凝胶是水合型结晶结构,具有片层结构。皮肤最外层的角质层中存在的角质层细胞间脂质其大部分也具有该α-凝胶结构。因此,对于皮肤而言,角质层细胞间脂质抑制从外部的物质入侵,以及从内部的水分蒸发,同时,通过其自身保持水分而具有保持皮肤柔软性或光滑外观的性能。已知在皮肤中,角质层以结合水的形式保持约33质量%的水分,角质层中角质层细胞间脂质保持约13质量%的结合水。α-gel is a hydrated crystal structure with a lamellar structure. Most of the stratum corneum intercellular lipid present in the stratum corneum, the outermost layer of the skin, also has this α-gel structure. Therefore, for the skin, the stratum corneum intercellular lipid suppresses the invasion of substances from the outside and the evaporation of water from the inside, and at the same time, has the property of maintaining softness or a smooth appearance of the skin by itself retaining water. It is known that in the skin, the stratum corneum holds about 33% by mass of water in the form of bound water, and the stratum corneum intercellular lipids in the stratum corneum hold about 13% by mass of bound water.
由此α-凝胶能够保持水分,因此,讨论其在化妆品等中的应用。The α-gel is thus capable of retaining moisture, and therefore, its use in cosmetics and the like is discussed.
例如,在专利文献1中,记载了含有神经酰胺类、甘油单脂肪酸酯、高级醇等的乳化组合物形成α-凝胶结构。For example, Patent Document 1 describes that an emulsified composition containing ceramides, monoglycerin fatty acid esters, higher alcohols, etc. forms an α-gel structure.
现有技术文献prior art literature
专利文献patent documents
专利文献1:特开2007-22997号公报Patent Document 1: JP-A-2007-22997
发明内容 Contents of the invention
本发明提供一种乳化组合物,其含有以下的成分(A)、(B)、(C)、(D)、(E)以及(F):The present invention provides an emulsified composition comprising the following components (A), (B), (C), (D), (E) and (F):
(A)甘油单脂肪酸酯;(A) glycerol monofatty acid ester;
(B)碳原子数为10~24的高级醇;(B) Higher alcohols with 10-24 carbon atoms;
(C)神经酰胺类;(C) Ceramides;
(D)阴离子表面活性剂;(D) Anionic surfactants;
(E)选自(聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷)交联聚合物、(聚二甲基硅氧烷/苯基乙烯基聚二甲基硅氧烷)交联聚合物以及(乙烯基聚二甲基硅氧烷/月桂基聚二甲基硅氧烷)交联聚合物中的1种或者2种以上的交联型聚硅氧烷;(E) selected from (Dimethicone/Vinyl Dimethicone) Crosspolymer, (Dimethicone/Phenyl Vinyl Dimethicone) One or more cross-linked polysiloxanes of cross-linked polymers and (vinyl dimethicone/lauryl dimethicone) cross-linked polymers;
(F)水,(F) water,
并且,成分(A)、(B)、(C)以及换算成酸的成分(D)的含量与成分(E)的含量的质量比例((A)+(B)+(C)+(D))/(E)为1~125。In addition, the mass ratio of the content of components (A), (B), (C) and the content of component (D) converted into acid to the content of component (E) ((A) + (B) + (C) + (D ))/(E) is 1~125.
附图说明 Description of drawings
[图1]是表示对实施例2的乳化组合物,通过光学显微镜观察时的照片的图。通过光学显微镜用普通光观察得到的照片(b),施加偏光观察得到的照片(a),以及照片(a)中的球状片层部分的放大照片(a1)。[ Fig. 1 ] is a diagram showing a photograph of the emulsified composition of Example 2 observed with an optical microscope. A photo (b) obtained by observing with ordinary light through an optical microscope, a photo (a) obtained by applying polarized light, and an enlarged photo (a1) of the spherical lamella part in photo (a).
发明内容Contents of the invention
本发明涉及稳定地含有神经酰胺,保湿效果高,并且抑制毛糙感,使用感优异的乳化组合物。The present invention relates to an emulsified composition that stably contains ceramide, has a high moisturizing effect, suppresses roughness, and is excellent in usability.
本发明者们发现,对于提高水分保持能力而设计的α-凝胶而言,通过以特定的比例使用特定的交联型聚硅氧烷,由于与涂布时在皮肤上形成的α-凝胶相独立,存在含有交联型聚硅氧烷的油滴,因此可以得到提高光滑感,抑制毛糙感,使用感优异的乳化组合物。The present inventors have found that, for α-gel designed to improve water retention, by using a specific cross-linked polysiloxane in a specific ratio, due to the α-gel formed on the skin when applied, The gum phase is independent, and there are oil droplets containing cross-linked polysiloxane, so it is possible to obtain an emulsified composition with improved smoothness, suppressed roughness, and excellent usability.
本发明的乳化组合物,其形成α-凝胶结构,防止神经酰胺结晶化而稳定地含有该神经酰胺,保湿效果高,并且提高光滑感,抑制毛糙感,使用感优异。The emulsified composition of the present invention forms an α-gel structure, prevents crystallization of ceramide and contains the ceramide stably, has a high moisturizing effect, improves smoothness, suppresses roughness, and has excellent usability.
本发明中的“毛糙感”是指如果将手指在皮肤上滑动以涂布乳化组合物,虽然希望以皮膜来覆盖,但却难以滑动,像使手指的动作停止那样的触感;“抑制毛糙感”是指如果将组合物同样涂布于皮肤上,不仅具有通过组合物覆盖皮肤的保护功能,并且具有适度的光滑和润滑,没有感觉到阻塞感。The "rough feeling" in the present invention means that if the finger slides on the skin to apply the emulsified composition, although it is desired to cover it with a film, it is difficult to slide, and the tactile feeling is like stopping the movement of the finger; " means that if the composition is also applied to the skin, it not only has the protective function of covering the skin with the composition, but also has moderate smoothness and lubricity, without feeling of clogging.
作为本发明所使用的成分(A)的甘油单脂肪酸酯,优选由碳原子数为10~24的直链脂肪酸得到的甘油单脂肪酸酯,例如,可以列举甘油单月桂酸酯、甘油单肉豆蔻酸酯、甘油单棕榈酸酯、甘油单硬脂酸酯、甘油单山嵛酸酯、甘油单油酸酯等。As the glycerol monofatty acid ester of the component (A) used in the present invention, a glycerol monofatty acid ester obtained from a straight-chain fatty acid having 10 to 24 carbon atoms is preferable, for example, glycerol monolaurate, glycerol monolaurate, Myristate, Glyceryl Monopalmitate, Glyceryl Monostearate, Glyceryl Monobehenate, Glyceryl Monooleate, etc.
其中,优选由碳原子数为18~22的直链脂肪酸得到的甘油单脂肪酸酯,更加优选甘油单棕榈酸酯、甘油单硬脂酸酯、甘油单山嵛酸酯。Among them, glycerol monofatty acid esters obtained from straight-chain fatty acids having 18 to 22 carbon atoms are preferred, and glycerol monopalmitate, glycerol monostearate, and glycerol monobehenate are more preferred.
成分(A)可以使用1种或者2种以上,从提高水分保持能力并且提高使用感的观点出发,其含量在全部组成中优选为0.001质量%以上,进一步优选为0.05质量%以上,更加优选为0.1质量%以上,并且优选为10质量%以下,进一步优选为3质量%以下,更加优选为2质量%以下。另外,成分(A)优选在本发明的乳化组合物中含有0.001~10质量%,进一步优选含有0.05~3质量%,更加优选含有0.1~2质量%。Component (A) can be used alone or in combination with two or more, and its content is preferably 0.001% by mass or more, more preferably 0.05% by mass or more, and still more preferably 0.1 mass % or more, and preferably 10 mass % or less, more preferably 3 mass % or less, still more preferably 2 mass % or less. In addition, the component (A) is preferably contained in the emulsified composition of the present invention at 0.001 to 10% by mass, more preferably at 0.05 to 3% by mass, and still more preferably at 0.1 to 2% by mass.
本发明所使用的成分(B)的高级醇为碳原子数为10~24的高级醇,例如,可以列举月桂醇、肉豆蔻醇、鲸蜡醇、硬脂醇、山嵛醇、油醇等。The higher alcohol of the component (B) used in the present invention is a higher alcohol having 10 to 24 carbon atoms, for example, lauryl alcohol, myristyl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, oleyl alcohol, etc. .
其中,优选碳原子数为14~22的高级醇,进一步优选鲸蜡醇、硬脂醇、山嵛醇。Among them, higher alcohols with 14 to 22 carbon atoms are preferred, and cetyl alcohol, stearyl alcohol, and behenyl alcohol are more preferred.
成分(B)可以使用1种或者2种以上,从提高水分保持能力的观点出发,其含量在全部组成中优选为0.001质量%以上,进一步优选为0.1质量%以上,并且优选为10质量%以下,进一步优选为3质量%以下,更加优选为2.5质量%以下。另外,成分(B)在本发明的乳化组合物中优选含有0.001~10质量%,进一步优选含有0.1~3质量%,更加优选含有0.1~2.5质量%。Component (B) can be used alone or in combination of two or more, and its content is preferably 0.001% by mass or more, more preferably 0.1% by mass or more, and preferably 10% by mass or less in the entire composition from the viewpoint of improving the moisture retention capacity , more preferably 3% by mass or less, even more preferably 2.5% by mass or less. In addition, the component (B) is preferably contained in the emulsified composition of the present invention at 0.001 to 10% by mass, more preferably at 0.1 to 3% by mass, and still more preferably at 0.1 to 2.5% by mass.
作为成分(C)的神经酰胺类,优选下列(I)天然来源的神经酰胺类、和/或(II)假型神经酰胺类。具体来说,(I)天然来源的神经酰胺类优选下列通式(1)所表示的神经酰胺类,(II)假型神经酰胺类优选下列通式(2)所表示的神经酰胺类。通过利用通式(1)或(2)的结构而和成分(A)、成分(B)、成分(D)混合在一起,由此可以形成层状片层的结构。As the ceramides of the component (C), the following (I) naturally-derived ceramides and/or (II) pseudotyped ceramides are preferable. Specifically, (I) naturally-derived ceramides are preferably ceramides represented by the following general formula (1), and (II) pseudotyped ceramides are preferably ceramides represented by the following general formula (2). By using the structure of the general formula (1) or (2) and mixing with the component (A), the component (B), and the component (D), a lamellar structure can be formed.
(I)通式(1)所表示的天然来源的神经酰胺类或者相同结构的合成物及其衍生物(以下,称为天然型神经酰胺)。(I) Naturally derived ceramides represented by the general formula (1) or synthetic compounds having the same structure and derivatives thereof (hereinafter referred to as natural ceramides).
(式中,R11表示可以被羟基取代的碳原子数为7~19的直链、支链或者环状的饱和或者不饱和的烃基;Z1表示亚甲基或者次甲基;X5、X6、以及X7分别独立地表示氢原子、羟基或者乙酰氧基;X8表示氢原子,或者和邻接的氧原子一起形成桥氧基(但是,当Z1为次甲基时,X5和X6中任意一个为氢原子,另一个不存在。当X8形成桥氧基时,X7不存在。);R12表示羟甲基或者乙酰氧甲基;R13表示氢原子、或者表示碳原子数为1~4的烷基;R14为可以被羟基取代的碳原子数为5~30的直链、支链或者环状的饱和或者不饱和的烃基,或者表示在该烷基的ω末端上通过酯键结合有可以被羟基取代的碳原子数为8~22的直链或者支链的饱和或者不饱和的脂肪酸的基团;虚线部分表示可以是不饱和键。)(In the formula, R 11 represents a linear, branched or cyclic saturated or unsaturated hydrocarbon group with 7 to 19 carbon atoms that can be substituted by a hydroxyl group; Z 1 represents a methylene or methine group; X 5 , X 6 and X 7 independently represent a hydrogen atom, hydroxyl or acetoxy; X 8 represents a hydrogen atom, or forms a bridging oxygen group with an adjacent oxygen atom (however, when Z 1 is a methine group, X 5 Any one of X and X 6 is a hydrogen atom, and the other does not exist. When X 8 forms a bridging oxygen group, X 7 does not exist.); R 12 represents a hydroxymethyl or acetoxymethyl group; R 13 represents a hydrogen atom, or Represents an alkyl group with 1 to 4 carbon atoms; R14 is a linear, branched or cyclic saturated or unsaturated hydrocarbon group with 5 to 30 carbon atoms that can be substituted by a hydroxyl group, or represents The end of the omega of the fatty acid is bonded with a straight-chain or branched saturated or unsaturated fatty acid group with a carbon number of 8 to 22 that can be substituted by a hydroxyl group through an ester bond; the dotted line indicates that it can be an unsaturated bond.)
成分(C)为:R11优选为碳原子数为7~19、更加优选碳原子数为13~15的直链烷基;R14优选为可以被羟基取代的碳原子数为9~27的直链烷基或者在碳原子数为9~27的直链烷基上通过酯键结合有亚油酸的基团。另外,X8优选表示氢原子,或者优选和氧原子一起形成桥氧基。进一步,作为R14,优选二十三烷基、1-羟基十五烷基、1-羟基二十三烷基、十七烷基、1-羟基十一烷基、ω位上通过酯键结合有亚油酸的二十九基。Component (C) is: R 11 is preferably a straight-chain alkyl group with 7 to 19 carbon atoms, more preferably 13 to 15 carbon atoms; R 14 is preferably a straight-chain alkyl group with 9 to 27 carbon atoms that may be substituted by a hydroxyl group A straight-chain alkyl group or a group in which linoleic acid is bonded to a straight-chain alkyl group with 9 to 27 carbon atoms through an ester bond. In addition, X 8 preferably represents a hydrogen atom, or preferably forms a bridging oxygen group together with an oxygen atom. Further, as R 14 , tricosyl, 1-hydroxypentadecyl, 1-hydroxytricosyl, heptadecyl, 1-hydroxyundecyl, and ω-position bonded by an ester bond are preferred. There are nineteen bases of linoleic acid.
作为天然型神经酰胺的具体例子,可以举出鞘氨醇、二氢鞘氨醇、植物鞘氨醇或者鞘氨二烯醇被酰胺化的神经酰胺1~7型(例如,J.LipidRes.,24:759(1983)的图2、以及J.Lipid.Res.,35:2069(1994)的图4中记载的猪以及人的神经酰胺类)。Specific examples of natural ceramides include ceramide types 1 to 7 in which sphingosine, dihydrosphingosine, phytosphingosine, or sphingosine is amidated (for example, J.LipidRes., 24:759 (1983) Figure 2, and J.Lipid.Res., 35:2069 (1994) Figure 4 described porcine and human ceramides).
进一步,也可以包含上述神经酰胺的N-烷基体(例如N-甲基体)。Furthermore, N-alkyl forms (for example, N-methyl forms) of the above-mentioned ceramides may also be included.
这些神经酰胺可以使用天然型(D(-)体)的光学活性体,也可以使用非天然型(L(+)体)的光学活性体,也可以进一步使用天然型和非天然型的混合物。上述化合物的立体构型可以是天然型立体构型的物质,也可以是除此以外的非天然型立体构型的物质,另外,也可以是它们的混合物。其中,优选CERAMIDE 1、CERAMIDE 2、CERAMIDE 3、CERAMIDE 5、CERAMIDE 6Ⅱ的化合物(以上根据INCI第八版)和用下式表示的物质。These ceramides may be natural type (D(-) body) optically active body, non-natural type (L(+) body) optically active body, or a mixture of natural type and non-natural type may be used. The stereoconfiguration of the above-mentioned compounds may be a substance having a natural stereoconfiguration, a substance having a non-natural stereoconfiguration other than that, or a mixture thereof. Among them, compounds of CERAMIDE 1, CERAMIDE 2, CERAMIDE 3, CERAMIDE 5, and CERAMIDE 6II (the above are based on INCI 8th edition) and substances represented by the following formula are preferable.
这些可以是来自天然的提取物和/或合成物中的任意种,也可以使用市售品。These may be any of natural extracts and/or synthetics, and commercially available ones may be used.
作为这样的天然型神经酰胺的市售品,可以举出Ceramide I、Ceramide III、Ceramide IIIA、Ceramide IIIB、Ceramide IIIC、CeramideVI(以上,Cosmofarm公司)、Ceramide TIC-001(高砂香料公司)、CERAMIDE II(Quest International公司)、DS-Ceramide VI、DS-CLA-Phytoceramide、C6-Phytoceramide、DS-ceramide Y3S(DOOSAN公司)、CERAMIDE 2(Sederma公司)。Commercially available products of such natural ceramides include Ceramide I, Ceramide III, Ceramide IIIA, Ceramide IIIB, Ceramide IIIC, Ceramide VI (above, Cosmofarm), Ceramide TIC-001 (Takasago Fragrance Co.), Ceramide II (Quest International), DS-Ceramide VI, DS-CLA-Phytoceramide, C6-Phytoceramide, DS-ceramide Y3S (DOOSAN), CERAMIDE 2 (Sederma).
(II)通式(2)表示的假型神经酰胺(pseudo-ceramide)。(II) Pseudo-ceramide represented by general formula (2).
(式中,R15表示可以被羟基取代的碳原子数为10~22的直链、支链或者环状的饱和或者不饱和的烃基,或表示氢原子;X9表示氢原子、乙酰基或者甘油基;R16为可以被羟基或者氨基取代的碳原子数为5~22的直链、支链或者环状的饱和或者不饱和的烃基,或者表示在该烃基的ω末端上通过酯键结合有可以被羟基取代的碳原子数为8~22的直链或者支链的饱和或者不饱和的脂肪酸的基团;R17表示氢原子,或者表示可以被羟基、羟基烷氧基、烷氧基或者乙酰氧基取代的总碳原子数为1~30的烷基。)(In the formula, R15 represents a linear, branched or cyclic saturated or unsaturated hydrocarbon group with 10-22 carbon atoms that can be substituted by a hydroxyl group, or represents a hydrogen atom; X9 represents a hydrogen atom, an acetyl group or Glyceryl; R 16 is a straight-chain, branched or cyclic saturated or unsaturated hydrocarbon group with 5-22 carbon atoms that can be substituted by hydroxyl or amino group, or it means that the omega end of the hydrocarbon group is bound by an ester bond There is a group of straight-chain or branched saturated or unsaturated fatty acids with 8 to 22 carbon atoms that can be substituted by hydroxyl; R 17 represents a hydrogen atom, or represents that it can be substituted by hydroxyl, hydroxyalkoxy, or alkoxy Or an alkyl group with a total carbon number of 1 to 30 substituted by an acetoxy group.)
作为R16,优选壬基、十三烷基、十五烷基、在ω位上通过酯键结合有亚油酸的十一烷基、在ω位上通过酯键结合有亚油酸的十五烷基、在ω位上通过酯键结合有12-羟基硬脂酸的十五烷基、在ω位上通过酰胺键结合有甲基支链异硬脂酸的十一烷基。R 16 is preferably nonyl, tridecyl, pentadecyl, undecyl in which linoleic acid is bonded at the ω position through an ester bond, and decadecyl group in which linoleic acid is bonded at the ω position through an ester bond. Pentaalkyl, pentadecyl in which 12-hydroxystearic acid is bonded via an ester bond at the ω position, and undecyl in which methyl branched isostearic acid is bonded to the ω position via an amide bond.
在R15为氢原子的情况下,R17为可以被羟基、羟基烷氧基、烷氧基或者乙酰氧基取代的总碳原子数为10~30、优选总碳原子数为12~20的烷基;在R15为可以被羟基取代的碳原子数为10~22的直链、支链或者环状的饱和或者不饱和的烃基的情况下,R17优选表示氢原子,或者表示可以被羟基、羟基烷氧基、烷氧基或者乙酰氧基取代的总碳原子数为1~8的烷基。作为R17的羟基烷氧基或者烷氧基,优选碳原子数为1~7的基团。When R 15 is a hydrogen atom, R 17 is 10 to 30 carbon atoms in total, preferably 12 to 20 carbon atoms in total, which may be substituted by hydroxyl, hydroxyalkoxy, alkoxy or acetoxy. Alkyl group; when R15 is a straight chain, branched chain or cyclic saturated or unsaturated hydrocarbon group with 10 to 22 carbon atoms that can be substituted by a hydroxyl group, R17 preferably represents a hydrogen atom, or represents that it can be replaced by An alkyl group with a total carbon number of 1 to 8 substituted by hydroxy, hydroxyalkoxy, alkoxy or acetoxy. The hydroxyalkoxy or alkoxy group of R17 is preferably a group having 1 to 7 carbon atoms.
作为通式(2),优选R15为十六烷基、X9为氢原子、R16为十五烷基、R17为羟乙基的化合物;R15为十六烷基、X9为氢原子、R16为壬基、R17为羟乙基的化合物的假型神经酰胺类(可以限定为下述化学式中的2种),更加优选通式(2)的R15为十六烷基、X9为氢原子、R16为十五烷基、R17为羟乙基的化合物(N-(十六烷氧基羟丙基)-N-羟乙基十六酰胺)。As general formula (2), it is preferred that R 15 is hexadecyl, X 9 is a hydrogen atom, R 16 is pentadecyl, R 17 is hydroxyethyl; R 15 is hexadecyl, X 9 is Pseudotype ceramides (can be limited to two types in the following chemical formulas) of a hydrogen atom, R 16 is a nonyl group, and R 17 is a hydroxyethyl group, more preferably R 15 of the general formula (2) is hexadecane group, X 9 is a hydrogen atom, R 16 is pentadecyl, and R 17 is a hydroxyethyl group (N-(hexadecyloxyhydroxypropyl)-N-hydroxyethyl hexadecylamide).
成分(C)的神经酰胺类可以使用1种或者2种,从使成分(C)充分浸透于皮肤的观点出发,其含量在全部组成中优选为0.001质量%以上,进一步优选为0.1质量%以上,更加优选为0.2质量%以上,并且优选为10质量%以下,进一步优选为5质量%以下,更加优选为3质量%以下。另外,成分(C)在本发明的乳化组合物中优选含有0.001~10质量%,进一步优选含有0.1~5质量%,更加优选含有0.2~3质量%。The ceramides of the component (C) can be used alone or in combination, and the content thereof is preferably 0.001% by mass or more, more preferably 0.1% by mass or more, based on the entire composition, from the viewpoint of sufficiently permeating the component (C) into the skin , more preferably 0.2% by mass or more, and preferably 10% by mass or less, still more preferably 5% by mass or less, even more preferably 3% by mass or less. In addition, the component (C) is preferably contained in the emulsified composition of the present invention at 0.001 to 10% by mass, more preferably at 0.1 to 5% by mass, and still more preferably at 0.2 to 3% by mass.
作为本发明所使用的成分(D)的阴离子表面活性剂,可以举出例如月桂酸钠、棕榈酸钾、硬脂酸精氨酸等由碳原子数为12~24的脂肪酸得到的脂肪酸盐;月桂基硫酸钠、月桂基硫酸钾等烷基硫酸酯盐;聚氧乙烯月桂基硫酸三乙醇胺等烷基醚硫酸酯盐;月桂酰基肌氨酸钠等N-酰基肌氨酸盐;N-硬脂酰基-N-甲基牛磺酸钠、N-肉豆蔻酰基-N-甲基牛磺酸钠等脂肪酸酰胺磺酸盐;单硬脂基磷酸钠等烷基磷酸盐;聚氧乙烯油烯基醚磷酸钠、聚氧乙烯硬脂基醚磷酸钠等聚氧乙烯烷基醚磷酸盐;二-2-乙基己基磺基琥珀酸钠等长链磺基琥珀酸盐;N-月桂酰基谷氨酸单钠、N-硬脂酰基-L-谷氨酸钠、N-硬脂酰基-L-谷氨酸精氨酸、N-硬脂酰谷氨酸钠、N-肉豆蔻酰基-L-谷氨酸钠等长链N-酰基谷氨酸盐等。Examples of the anionic surfactant used in the present invention as component (D) include fatty acid salts obtained from fatty acids having 12 to 24 carbon atoms, such as sodium laurate, potassium palmitate, and arginine stearate. Alkyl sulfates such as sodium lauryl sulfate and potassium lauryl sulfate; Alkyl ether sulfates such as polyoxyethylene lauryl sulfate triethanolamine; N-acyl sarcosinates such as sodium lauryl sarcosinate; N- Fatty acid amide sulfonates such as sodium stearyl-N-methyl taurate and sodium N-myristoyl-N-methyl taurate; alkyl phosphates such as sodium monostearyl phosphate; polyoxyethylene oil Polyoxyethylene alkyl ether phosphates such as sodium alkenyl ether phosphate and sodium polyoxyethylene stearyl ether phosphate; long-chain sulfosuccinates such as sodium di-2-ethylhexyl sulfosuccinate; N-lauroyl Monosodium Glutamate, Sodium N-Stearyl-L-Glutamate, N-Stearyl-L-Glutamate Arginine, Sodium N-Stearyl Glutamate, N-Myristoyl- L-sodium glutamate and other long-chain N-acyl glutamate, etc.
其中,优选由碳原子数为12~24的脂肪酸得到的脂肪酸盐、由碳原子数为14~22的脂肪酸得到的脂肪酸酰胺磺酸盐、具有碳原子数为14~22的烷基的聚氧乙烯烷基醚磷酸盐、由碳原子数为12~22的脂肪酸得到的N-酰基谷氨酸盐,作为盐,优选钠盐、精氨酸盐。进一步优选由碳原子数为18~22的脂肪酸得到的酰胺磺酸盐、具有碳原子数为18~22的烷基的聚氧乙烯烷基醚磷酸盐、由碳原子数为18~22的脂肪酸得到的N-酰基谷氨酸盐,更加优选选自N-硬脂酰基-N-甲基牛磺酸钠、N-硬脂酰基-L-谷氨酸精氨酸、聚氧乙烯硬脂基醚磷酸钠中的1种或者2种以上。Among them, fatty acid salts obtained from fatty acids with 12 to 24 carbon atoms, fatty acid amide sulfonates obtained from fatty acids with 14 to 22 carbon atoms, and polyamides with alkyl groups with 14 to 22 carbon atoms are preferred. Oxyethylene alkyl ether phosphate, N-acyl glutamate obtained from a fatty acid having 12 to 22 carbon atoms, and as a salt, sodium salt and arginine salt are preferable. Further preferred are amide sulfonates obtained from fatty acids with 18 to 22 carbon atoms, polyoxyethylene alkyl ether phosphates with alkyl groups with 18 to 22 carbon atoms, fatty acids with 18 to 22 carbon atoms The obtained N-acyl glutamate is more preferably selected from N-stearyl-N-methyl taurate sodium, N-stearyl-L-glutamic acid arginine, polyoxyethylene stearyl One or more of sodium ether phosphates.
成分(D)可以使用1种或者2种以上,从抑制成分(C)的结晶化的观点出发,成分(D)的含量换算成酸在全部组成中优选为0.01质量%以上,进一步优选为0.05质量%以上,更加优选为0.1质量%以上,并且优选为3质量%以下,进一步优选为2质量%以下,更加优选为1.5质量%以下。另外,成分(D)的含量换算成酸在本发明的乳化组合物中优选为0.01~3质量%,进一步优选为0.05~2质量%,更加优选为0.1~1.5质量%。Component (D) can be used alone or in combination of two or more. From the viewpoint of suppressing the crystallization of component (C), the content of component (D) is preferably 0.01 mass % or more in terms of acid in the entire composition, more preferably 0.05% by mass. Mass % or more, more preferably 0.1 mass % or more, and preferably 3 mass % or less, still more preferably 2 mass % or less, still more preferably 1.5 mass % or less. In addition, the content of the component (D) is preferably 0.01 to 3% by mass, more preferably 0.05 to 2% by mass, and still more preferably 0.1 to 1.5% by mass in terms of acid in the emulsified composition of the present invention.
另外,成分(D)是通过酸型化合物和碱中和得到的化合物,成分(D)的含量为作为酸型化合物的含量或者换算成酸的含量。In addition, the component (D) is a compound obtained by neutralizing an acidic compound and a base, and the content of the component (D) is the content as an acidic compound or the content converted into an acid.
本发明中使用的成分(E)的交联型聚硅氧烷为选自(聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷)交联聚合物、(聚二甲基硅氧烷/苯基乙烯基聚二甲基硅氧烷)交联聚合物以及(乙烯基聚二甲硅氧烷/月桂基聚二甲基硅氧烷)交联聚合物中的1种或者2种以上的交联型聚硅氧烷。这些的联型聚硅氧烷优选将其分散于水性介质或者油性介质中作为配合材料使用。The cross-linked polysiloxane of component (E) used in the present invention is selected from (polydimethylsiloxane/vinyl polydimethylsiloxane) cross-linked polymer, (polydimethylsiloxane Oxane/Phenylvinyl Dimethicone) Crosspolymer and (Vinyl Dimethicone/Lauryl Dimethicone) Crosspolymer More than one cross-linked polysiloxane. These bi-polysiloxanes are preferably dispersed in an aqueous medium or an oily medium and used as a compounding material.
交联型聚硅氧烷为含有三维结合的硅酮,例如,交联型甲基聚硅氧烷为具有将甲基聚硅氧烷三维交联而成的交联结构的聚合物,可以按照常用方法制造。例如,交联型甲基聚硅氧烷是在使二甲基二甲氧硅烷或二甲基二氯硅烷等聚合来构筑硅酮链时,使二甲基甲氧基乙烯基硅烷或氯代二甲基乙烯基硅烷等共存而进行共聚,此后使乙烯基之间聚合来构筑交联结构而制成。另外,在使二甲氧基二甲基硅氧烷聚合制造甲基聚硅氧烷时,通过加入少量甲基三甲氧基硅氧烷作为交联剂,可以导入三维交联结构。Cross-linked polysiloxane is a silicone containing three-dimensional bonding, for example, cross-linked methyl polysiloxane is a polymer having a cross-linked structure formed by three-dimensionally cross-linked methyl polysiloxane, and can be obtained according to Common method of manufacture. For example, cross-linked methylpolysiloxane is made by polymerizing dimethyldimethoxysilane or dimethyldichlorosilane to construct a silicone chain, and dimethylmethoxyvinylsilane or chlorinated Copolymerized with dimethylvinylsilane and the like, and then polymerized between vinyl groups to construct a crosslinked structure. In addition, when dimethoxydimethylsiloxane is polymerized to produce methylpolysiloxane, a three-dimensional crosslinked structure can be introduced by adding a small amount of methyltrimethoxysiloxane as a crosslinking agent.
作为成分(E)的交联型聚硅氧烷从应用于皮肤的观点出发,更加优选(聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷)交联聚合物。The cross-linked polysiloxane as the component (E) is more preferably a (polydimethylsiloxane/vinyl dimethicone) cross-linked polymer from the viewpoint of skin application.
另外,交联型聚硅氧烷优选将其分散于油性介质中使用。作为油性介质,可以列举环戊硅氧烷、聚二甲基硅氧烷、角鲨烷、矿物油、异十二烷、二苯基甲硅烷氧基苯基聚三甲基硅氧烷等在25℃下为液状的油性介质(烃油、极性油)。In addition, the crosslinked polysiloxane is preferably used by dispersing it in an oily medium. Examples of the oily medium include cyclopentasiloxane, dimethicone, squalane, mineral oil, isododecane, diphenylsiloxyphenyl trimethicone, etc. Liquid oily medium (hydrocarbon oil, polar oil) at 25°C.
作为这些的交联型聚硅氧烷的市售品,可以列举KSG-15、KSG-16、KSG-1610、KSG-18A、KSG-41、KSG-42、KSG-43、KSG-44(以上为信越化学工业公司制造),可以列举9546 Silicone Elastomer Blend(DowCorning Toray公司制造)、SFE839(Momentive Performance Materials Inc.制造)等。Commercially available products of these cross-linked polysiloxanes include KSG-15, KSG-16, KSG-1610, KSG-18A, KSG-41, KSG-42, KSG-43, KSG-44 (above Shin-Etsu Chemical Co., Ltd.), 9546 Silicone Elastomer Blend (manufactured by Dow Corning Toray Co.), SFE839 (manufactured by Momentive Performance Materials Inc.), and the like are exemplified.
成分(E)在本发明的乳化组合物中,与涂布时在皮肤上存在的层状片层结构或少量存在的球状片层相独立,与油性介质等一起作为独立的油滴而存在,可以提高涂布时的光滑感,抑制毛糙感,得到优异的使用感。In the emulsified composition of the present invention, the component (E) exists as independent oil droplets together with an oily medium, independently of the layered lamellar structure existing on the skin at the time of application or a small amount of spherical lamellar layers, It can improve the smooth feeling at the time of coating, suppress the rough feeling, and obtain an excellent feeling in use.
成分(E)可以使用1种以上,从抑制发粘并且提高光滑感、抑制毛糙感的观点出发,在本发明的乳化组合物中优选含有0.0025~4质量%,进一步优选含有0.01~3质量%,更加优选含有0.03~2质量%。成分(E)的含量从抑制发粘的观点出发,优选为4质量%以下,进一步优选为3质量%以下,更加优选为2质量%以下,从抑制毛糙感的观点出发,优选为0.0025质量%以上,进一步优选为0.01质量%以上,更加优选为0.03质量%以上。Component (E) can be used at least one kind, and it is preferably contained in the emulsified composition of the present invention in an amount of 0.0025 to 4% by mass, more preferably in an amount of 0.01 to 3% by mass, from the viewpoint of suppressing stickiness, improving smoothness, and suppressing roughness. , more preferably 0.03 to 2% by mass. The content of component (E) is preferably 4% by mass or less from the viewpoint of stickiness suppression, more preferably 3% by mass or less, still more preferably 2% by mass or less, and preferably 0.0025% by mass from the viewpoint of suppressing roughness Above, more preferably 0.01% by mass or more, still more preferably 0.03% by mass or more.
在本发明中,从防止神经酰胺的结晶化以提高稳定性,抑制毛糙感的观点出发,成分(A)、(B)、(C)以及换算成酸的成分(D)的含量和成分(E)的含量的质量比例为((A)+(B)+(C)+(D))/(E)=1~125,优选为1.5~100,进一步优选为3~70,更加优选为3.5~70。从抑制发粘的观点出发,质量比例((A)+(B)+(C)+(D))/(E)为1以上,优选为1.5以上,进一步优选为3以上,更加优选为3.5以上,从抑制毛糙感的观点出发,为125以下,优选为100以下,进一步优选为70以下。In the present invention, the content of components (A), (B), and (C) and component (D) in terms of acid and the content of components ( The mass ratio of the content of E) is ((A)+(B)+(C)+(D))/(E)=1~125, preferably 1.5~100, more preferably 3~70, more preferably 3.5~70. From the viewpoint of stickiness suppression, the mass ratio ((A)+(B)+(C)+(D))/(E) is 1 or more, preferably 1.5 or more, more preferably 3 or more, still more preferably 3.5 As mentioned above, from the viewpoint of suppressing roughness, it is 125 or less, preferably 100 or less, and more preferably 70 or less.
进一步,从防止神经酰胺的结晶化以提高稳定性,抑制毛糙感的观点出发,成分(B)和(C)的含量的质量比例((B)/(C))优选为0.2~5,进一步优选为0.25~4,更加优选为0.3~4。通过将上述质量比例设定为上述范围,可以得到由成分(A)~(D)构成的层状片层和少量球状片层、和含有成分(E)的个别油滴共存,并且片层结构被保持以防止神经酰胺的结晶化,在涂布于皮肤上时具有保湿性,抑制毛糙感的乳化组合物。Furthermore, from the standpoint of preventing crystallization of ceramide to improve stability and suppress roughness, the mass ratio ((B)/(C)) of the components (B) and (C) is preferably 0.2 to 5, and further Preferably it is 0.25~4, More preferably, it is 0.3~4. By setting the above-mentioned mass ratio to the above-mentioned range, lamellar sheets composed of components (A) to (D), a small amount of spherical sheets, and individual oil droplets containing component (E) can coexist, and the sheet structure An emulsified composition that prevents crystallization of ceramide, has moisturizing properties when applied to the skin, and suppresses roughness.
另外,从防止神经酰胺的结晶化以提高稳定性,抑制毛糙感的观点出发,换算成酸的成分(D)的含量和成分(E)的含量的质量比例((D)/(E))优选为0.1~15,进一步优选为0.2~12,更加优选为0.4~10。In addition, the mass ratio ((D)/(E)) of the content of the component (D) and the content of the component (E) in terms of acid conversion is calculated from the viewpoint of preventing the crystallization of ceramide, improving stability, and suppressing roughness Preferably it is 0.1-15, More preferably, it is 0.2-12, More preferably, it is 0.4-10.
在本发明中,成分(F)的水在本发明的乳化组合物中优选含有20质量%以上且99质量%以下,更加优选含有40质量%以上且90质量%以下。In the present invention, the water of the component (F) is preferably contained in the emulsified composition of the present invention in a range of 20% by mass to 99% by mass, more preferably in a range of 40% by mass to 90% by mass.
另外,还可以含有其它的水性基剂,例如乙醇、丙醇等碳原子数为1~4的低级醇等。另外,成分(F)的水的含量在分两次配合情况下,是最初的水(F1)和第2次配合的水(F2)和各成分中含有的水(F3)的含量的合计。In addition, other water-based base agents may also be included, such as lower alcohols with 1 to 4 carbon atoms such as ethanol and propanol. In addition, when the water content of the component (F) is mixed twice, it is the sum of the contents of the first water (F1), the second water (F2) and the water (F3) contained in each component.
本发明的乳化组合物进一步从更抑制毛糙感的观点出发,更加优选含有(G)IOB为1.5~3.5的多元醇。The emulsified composition of the present invention further preferably contains (G) a polyhydric alcohol having an IOB of 1.5 to 3.5 from the viewpoint of further suppressing roughness.
在此,IOB表示基于有机概念图(藤田穆,有机化合物的预测和有机概念图,化学的领域Vol.11,No.10(1957)719-725)求得的无机性值和有机性值的比(Inorganic Organic Balance),通过下式求得。Here, IOB represents the combination of inorganic and organic values obtained based on the organic concept map (Fujita Mu, Prediction of Organic Compounds and Organic Concept Map, Field of Chemistry Vol.11, No.10(1957)719-725) Ratio (Inorganic Organic Balance), obtained by the following formula.
具体来说,可以列举直链或者支链型的二醇、单烷基单烷基二醇醚、单烷基二烷基二醇醚、或者单烷基三烷基二醇醚、聚乙二醇、聚丙二醇、聚氧乙烯二醇。更具体而言,可以列举1,3-丁二醇(IOB=2.50)、异戊二醇(IOB=2.0)、丙二醇(IOB=3.33)、1,3-丙二醇(IOB=3.33)、二丙二醇(IOB=1.83)等的碳原子数为2~10的二醇;二乙二醇单乙基醚(IOB=1.6)、分子量为100~1万的聚丙二醇、分子量为100~1万的聚乙二醇、环氧乙烷的平均加成摩尔数为4~20的聚氧乙烯二甘油醚。Specifically, linear or branched glycols, monoalkyl monoalkyl glycol ethers, monoalkyl dialkyl glycol ethers, or monoalkyl trialkyl glycol ethers, polyethylene glycol ethers, alcohol, polypropylene glycol, polyoxyethylene glycol. More specifically, 1,3-butanediol (IOB=2.50), isopentyl glycol (IOB=2.0), propylene glycol (IOB=3.33), 1,3-propanediol (IOB=3.33), dipropylene glycol (IOB=1.83) and other diols with carbon atoms of 2 to 10; diethylene glycol monoethyl ether (IOB=1.6), polypropylene glycol with a molecular weight of 1 million to 10,000, and poly Polyoxyethylene diglyceryl ether with an average addition mole number of ethylene glycol and ethylene oxide of 4 to 20.
成分(G)的多元醇可以使用1种或者2种以上,从进一步抑制毛糙感的观点出发,优选在本发明的乳化组合物中含有0.001~20质量%,进一步优选含有0.2~20质量%,更加优选含有2~20质量%,从抑制发粘感并且提高清爽湿润感的观点出发,优选为0.2~15质量%,进一步优选含有2~10质量%。The polyhydric alcohol of component (G) can be used 1 type or 2 or more types, From a viewpoint of further suppressing roughness, it is preferable to contain 0.001-20 mass % in the emulsified composition of this invention, and it is more preferable to contain 0.2-20 mass %, It is more preferable to contain 2-20 mass %, and it is preferable to contain 0.2-15 mass % from a viewpoint of suppressing a sticky feeling and improving refreshing moist feeling, and it is more preferable to contain 2-10 mass %.
从进一步抑制毛糙感并抑制发粘的观点出发,成分(A)、(B)、(C)以及换算成酸的成分(D)的合计的含量和成分(G)的含量的质量比例(((A)+(B)+(C)+(D))/(G))优选为0.1~20,进一步优选为0.2~16,更进一步优选为0.3~4。质量比例(((A)+(B)+(C)+(D))/(G))从抑制发粘的观点出发优选为0.1以上,进一步优选为0.2以上,更加优选为0.3以上,从进一步抑制毛糙感的观点出发优选为20以下,进一步优选为16以下,更加优选为4以下。From the viewpoint of further suppressing roughness and stickiness, the mass ratio of the total content of components (A), (B), and (C) and component (D) converted to acid to the content of component (G) (( (A)+(B)+(C)+(D))/(G)) is preferably 0.1-20, more preferably 0.2-16, still more preferably 0.3-4. The mass ratio (((A)+(B)+(C)+(D))/(G)) is preferably 0.1 or more, more preferably 0.2 or more, and still more preferably 0.3 or more from the viewpoint of stickiness suppression. From the viewpoint of further suppressing roughness, it is preferably 20 or less, more preferably 16 or less, and still more preferably 4 or less.
本发明的乳化组合物中,进一步可以含有上述以外(成分(B)、(C)、(E)以外)的油剂。例如,可以列举液体石蜡、氢化聚异丁烯、氢化聚癸烯、角鲨烷、凡士林等烃油;硬脂酸、山嵛酸、异肉豆蔻酸等高级脂肪酸;橄榄油、霍霍巴油等植物油;二甲基聚硅氧烷(甲基聚硅氧烷)、环状二甲基聚硅氧烷、甲基苯基聚硅氧烷、氨基改性硅酮、羧基改性硅酮、醇改性硅酮、烷基改性硅酮、聚醚改性硅酮、氟改性硅酮等硅油;全氟烷基乙基磷酸、全氟烷基聚氧乙烯磷酸、全氟聚醚、聚四氟乙烯等氟类油等。The emulsified composition of the present invention may further contain an oil agent other than the above (other than components (B), (C), and (E)). For example, hydrocarbon oils such as liquid paraffin, hydrogenated polyisobutylene, hydrogenated polydecene, squalane, and petrolatum; higher fatty acids such as stearic acid, behenic acid, and isomyristic acid; vegetable oils such as olive oil and jojoba oil; Dimethicone (methylpolysiloxane), cyclic dimethylpolysiloxane, methylphenylpolysiloxane, amino-modified silicone, carboxyl-modified silicone, alcohol-modified Silicone, alkyl modified silicone, polyether modified silicone, fluorine modified silicone and other silicone oils; perfluoroalkyl ethyl phosphoric acid, perfluoroalkyl polyoxyethylene phosphoric acid, perfluoropolyether, polytetrafluoroethylene Fluorinated oils such as ethylene, etc.
这些油剂优选在全部组成中不含有或者含有20质量%以下。These oil agents are preferably not contained or contained in an amount of 20% by mass or less in the entire composition.
另外,本发明的乳化组合物可以在不阻碍本发明效果的范围内,含有通常的化妆品中使用的有效成分或添加剂,例如,抗坏血酸、烟酸酰胺、烟酸等水溶性维生素类;黄柏提取物、甘草提取物、芦荟提取物、问荆提取物、茶提取物、黄瓜提取物、丁香提取物、人参提取物、金缕梅(Hamamelis)提取液、胎盘提取物、海藻提取物、七叶树提取物、洋甘菊提取物、柚子提取物、丁香提取物、药蜀葵提取物、褐藻提取物、罗汉柏提取物、蜂王浆提取物、桉树提取物等动·植物提取液;氢氧化钾、氢氧化钠、三乙醇胺、碳酸钠等碱;柠檬酸、酒石酸、乳酸、磷酸、琥珀酸、己二酸等酸;羧乙烯基聚合物、海藻酸钠、卡拉胶、羧甲基纤维素、羟乙基纤维素、瓜尔胶、黄原胶、羧甲基壳聚糖、透明质酸钠、噁唑啉改性硅酮、N,N-二甲基氨乙基甲基丙烯酸二乙酯硫酸盐·N,N-二甲基丙烯酰胺·二甲基丙烯酸聚乙二醇共聚物等增粘剂等。In addition, the emulsified composition of the present invention may contain active ingredients or additives commonly used in cosmetics, such as water-soluble vitamins such as ascorbic acid, niacinamide, and niacin; , licorice extract, aloe vera extract, quince extract, tea extract, cucumber extract, clove extract, ginseng extract, witch hazel (Hamamelis) extract, placenta extract, seaweed extract, horse chestnut Extract, Chamomile Extract, Grapefruit Extract, Clove Extract, Marshmallow Extract, Brown Algae Extract, Podocarpus Extract, Royal Jelly Extract, Eucalyptus Extract and other animal and plant extracts; Potassium Hydroxide, Sodium Hydroxide , triethanolamine, sodium carbonate and other bases; citric acid, tartaric acid, lactic acid, phosphoric acid, succinic acid, adipic acid and other acids; carboxyvinyl polymer, sodium alginate, carrageenan, carboxymethyl cellulose, hydroxyethyl cellulose Sulfate, Guar Gum, Xanthan Gum, Carboxymethyl Chitosan, Sodium Hyaluronate, Oxazoline Modified Silicone, N,N-Dimethylaminoethyl Methacrylate Diethyl Sulfate N , N-dimethylacrylamide · dimethacrylic acid polyethylene glycol copolymer and other tackifiers.
本发明的乳化组合物例如可以通过以下的制造方法(1)~(3)中的任意种来制造,作为水包油型乳化组合物而得到。The emulsified composition of the present invention can be produced, for example, by any of the following production methods (1) to (3), and can be obtained as an oil-in-water emulsified composition.
(1)包括以下工序:将含有成分(A)、(B)和(C)的第1油相在80~90℃下加热混合并搅拌的工序;接着,添加加热至80~90℃的含有成分(D)的酸型化合物和碱、以及成分(F)的一部分(F1)的第1水相的工序;接着,添加加热至80~90℃的混合其它油性成分的第2油相并搅拌的工序;在搅拌下冷却至25℃的工序;然后,进一步边添加作为剩余的成分(F)的(F2)和其它的水溶性成分(第2水相)边混合的工序。成分(E)可以和第1油相混合,也可以和第2油相混合。(1) It includes the following steps: heating, mixing and stirring the first oil phase containing components (A), (B) and (C) at 80-90°C; The process of the first water phase of the acid type compound and base of the component (D), and a part (F1) of the component (F); then, the second oil phase mixed with other oily components heated to 80~90°C is added and stirred The process; the process of cooling to 25° C. under stirring; and the process of further mixing while adding (F2) and other water-soluble components (second aqueous phase) as the remaining component (F). Component (E) may be mixed with the first oil phase or may be mixed with the second oil phase.
(2)包括以下工序:将在成分(A)、(B)以及(C)中含有成分(D)的酸型化合物的第1油相在80~90℃下加热混合并搅拌的工序;接着,添加加热至80~90℃的含有用于中和成分(D)的碱和成分(F)的一部分(F1)的第1水相并混合的工序;接着,混合加热至80~90℃的其它油性成分(第2油相)的工序;在搅拌下冷却至25℃的工序;然后,进一步边添加作为剩余的成分(F)的(F2)和其它的水溶性成分(第2水相)边混合的工序。成分(E)可以和第1油相混合,也可以和第2油相混合。(2) including the following steps: a step of heating, mixing and stirring the first oil phase containing the acid type compound of the component (D) in the components (A), (B) and (C) at 80 to 90° C.; then , the process of adding and mixing the first aqueous phase containing the alkali for neutralizing the component (D) and a part (F1) of the component (F) heated to 80-90°C; then, mixing and heating to 80-90°C Process of other oil-based components (second oil phase); process of cooling to 25°C with stirring; then, adding (F2) and other water-soluble components (second water phase) as the remaining component (F) side mixing process. Component (E) may be mixed with the first oil phase or may be mixed with the second oil phase.
(3)包括以下工序:将在成分(A)、(B)以及(C)中含有成分(D)的酸型化合物的一部分的第1油相在80~90℃下加热混合并搅拌的工序;接着,添加加热至80~90℃的含有成分(D)的剩余的酸型化合物和碱以及成分(F)的一部分(F1)的第1水相并混合搅拌的工序;接着,混合搅拌加热至80~90℃的其它油性成分(第2油相)的工序;在搅拌下冷却至25℃的工序;然后,进一步边添加作为剩余的成分(F)的(F2)和其它的水溶性成分(第2水相)边混合的工序。成分(E)可以混合于第1油相中,也可以混合于第2油相中。(3) Including the step of heating, mixing and stirring the first oil phase containing a part of the acid type compound of the component (D) among the components (A), (B) and (C) at 80 to 90°C ; Next, the process of adding and mixing the first aqueous phase containing the remaining acidic compound and alkali containing component (D) and a part (F1) of component (F) heated to 80~90°C; then, mixing and stirring The process of other oily components (second oil phase) to 80~90°C; the process of cooling to 25°C while stirring; and then, adding (F2) and other water-soluble components as the remaining component (F) (Second aqueous phase) while mixing. Component (E) may be mixed in the first oil phase, or may be mixed in the second oil phase.
上述制造方法(1)~(3)中的冷却不限于冷却至25℃,可以冷却至40℃以下的室温,优选冷却至30℃以下,并且优选冷却至15℃以上,更优选冷却至20℃以上。The cooling in the above production methods (1) to (3) is not limited to cooling to 25°C, but may be cooled to room temperature below 40°C, preferably below 30°C, preferably above 15°C, more preferably below 20°C above.
如以上所述,本发明的组合物从制造性以及稳定性的观点出发,优选具有加热混合成分(A)~(D)的工序。As described above, the composition of the present invention preferably has a step of heating and mixing components (A) to (D) from the viewpoint of manufacturability and stability.
在上述制造方法中,从生产性和经时稳定性的观点出发,优选制造方法(1)或者(2),进一步优选制造方法(1)。另外,在制造方法(1)或者(2)中,第1水相中成分(F)中的(F1)优选为制造后的乳化组合物总量的10~50质量%,进一步优选为15~45质量%,成分(F)中(F1)的量是使成分(D)的酸型化合物被碱中和,成为溶解状态的量即可。Among the above-mentioned production methods, the production method (1) or (2) is preferable, and the production method (1) is more preferable from the viewpoint of productivity and stability over time. In addition, in the production method (1) or (2), (F1) in the component (F) in the first aqueous phase is preferably 10 to 50% by mass of the total amount of the emulsified composition after production, more preferably 15 to 50% by mass. 45% by mass, and the amount of (F1) in the component (F) may be such that the acidic compound of the component (D) is neutralized by a base and brought into a dissolved state.
得到的乳化组合物为α-凝胶(α型结晶),结晶(γ型结晶)的析出被抑制。α-凝胶可以通过广角X射线衍射(Bragg角21~23°)进行结构分析来确认。α型结构为六方晶系,亲油基相对于亲水基层的面呈直角取向,其特征为在Bragg角21~23°附近出现一个尖锐的衍射峰。The obtained emulsified composition is an α-gel (α-type crystal), and precipitation of crystals (γ-type crystal) is suppressed. The α-gel can be confirmed by structural analysis by wide-angle X-ray diffraction (Bragg angle 21~23°). The α-type structure is a hexagonal crystal system, and the lipophilic group is oriented at right angles to the surface of the hydrophilic base layer. It is characterized by a sharp diffraction peak near the Bragg angle of 21~23°.
进一步,由成分(A)~(D)形成层状片层,通过小角X射线衍射(Bragg角0.3~5°)可以在Bragg角为1:2:3:4的比处确认有峰。将本发明的乳化组合物用离心分离机浓缩后再通过小角X射线衍射测定。如上面所述,本发明的乳化组合物,其连续相为水相,含有由成分(A)~(D)形成的层状片层和球状片层、以及含有成分(E)的交联型聚硅氧烷的油滴这三种油滴,这样的结构可以通过光学显微镜、广角X射线衍射、小角X射线衍射来确认。Furthermore, components (A) to (D) form lamellar sheets, and peaks can be confirmed at the Bragg angle ratio of 1:2:3:4 by small-angle X-ray diffraction (Bragg angle 0.3-5°). After concentrating the emulsified composition of the present invention with a centrifuge, it is measured by small-angle X-ray diffraction. As mentioned above, the continuous phase of the emulsified composition of the present invention is an aqueous phase, which contains lamellar sheets and spherical sheets formed of components (A) to (D), and a cross-linked type containing component (E). Such structures of the three types of oil droplets of polysiloxane can be confirmed by optical microscopy, wide-angle X-ray diffraction, and small-angle X-ray diffraction.
另外,本发明的乳化组合物优选为水包油型乳化组合物,例如适合作为化妆水、乳液、乳霜、凝胶等化妆品或皮肤外用剂。In addition, the emulsified composition of the present invention is preferably an oil-in-water emulsified composition, and is suitable as, for example, cosmetics such as lotion, lotion, cream, and gel, or external skin preparations.
进一步,本发明的乳化组合物可以涂布于皮肤上使用,可以在用于制造皮肤涂布剂中使用。Furthermore, the emulsified composition of the present invention can be used for coating on the skin, and can be used for producing a skin coating agent.
关于上述的实施方式,本发明进一步公开以下的组合物、制造方法、用途。Regarding the above-mentioned embodiments, the present invention further discloses the following compositions, production methods, and uses.
[1]一种乳化组合物,其含有以下成分(A)、(B)、(C)、(D)、(E)以及(F):[1] An emulsified composition containing the following components (A), (B), (C), (D), (E) and (F):
(A)甘油单脂肪酸酯;(A) glycerol monofatty acid ester;
(B)碳原子数为10~24的高级醇;(B) Higher alcohols with 10-24 carbon atoms;
(C)神经酰胺类;(C) Ceramides;
(D)阴离子表面活性剂;(D) Anionic surfactants;
(E)选自(聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷)交联聚合物、(聚二甲基硅氧烷/苯基乙烯基聚二甲基硅氧烷)交联聚合物以及(乙烯基聚二甲基硅氧烷/月桂基聚二甲基硅氧烷)交联聚合物中的1种或者2种以上的交联型聚硅氧烷;(E) selected from (Dimethicone/Vinyl Dimethicone) Crosspolymer, (Dimethicone/Phenyl Vinyl Dimethicone) One or more cross-linked polysiloxanes of cross-linked polymers and (vinyl dimethicone/lauryl dimethicone) cross-linked polymers;
(F)水,(F) water,
并且,成分(A)、(B)、(C)以及换算成酸的成分(D)的含量和成分(E)的含量的质量比例((A)+(B)+(C)+(D))/(E)为1~125。In addition, the mass ratio of components (A), (B), (C) and the content of component (D) converted into acid to the content of component (E) ((A) + (B) + (C) + (D ))/(E) is 1~125.
[2]如上述[1]所述的乳化组合物,其中,成分(E)为(聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷)交联聚合物。[2] The emulsified composition according to the above [1], wherein the component (E) is a (dimethicone/vinyl dimethicone) crosslinked polymer.
[3]如上述[1]或[2]所述的乳化组合物,其中,换算成酸的成分(D)的含量和成分(E)的含量的质量比例(D)/(E)为0.1~15,优选为0.2~12,进一步优选为0.4~10。[3] The emulsified composition according to the above [1] or [2], wherein the mass ratio (D)/(E) of the content of the component (D) in terms of acid and the content of the component (E) is 0.1 ~15, preferably 0.2~12, more preferably 0.4~10.
[4]如上述[1]~[3]中任一项所述的乳化组合物,其中,进一步含有(G)IOB为1.5~3.5的多元醇。[4] The emulsified composition according to any one of [1] to [3] above, further comprising (G) a polyhydric alcohol having an IOB of 1.5 to 3.5.
[5]如上述[1]~[4]中任一项所述的乳化组合物,其中,进一步含有上述(B)、(C)、(E)以外的油剂。[5] The emulsified composition according to any one of the above [1] to [4], which further contains an oil agent other than the above (B), (C), and (E).
[6]如上述[1]~[5]中任一项所述的乳化组合物,其中,成分(A)、(B)、(C)以及换算成酸的成分(D)的含量和成分(E)的含量的质量比例((A)+(B)+(C)+(D))/(E)为1.5~100,优选为3~70,进一步优选为3.5~70。[6] The emulsified composition according to any one of [1] to [5] above, wherein the contents and components of components (A), (B), and (C) and component (D) in terms of acid The mass ratio ((A)+(B)+(C)+(D))/(E) of the content of (E) is 1.5-100, preferably 3-70, more preferably 3.5-70.
[7]如上述[1]~[6]中任一项所述的乳化组合物,其中,成分(B)和(C)的含量的质量比(B)/(C)为0.2~5,优选为0.25~4,更加优选为0.3~4。[7] The emulsified composition according to any one of [1] to [6] above, wherein the mass ratio (B)/(C) of the components (B) and (C) is 0.2 to 5, Preferably it is 0.25~4, More preferably, it is 0.3~4.
[8]如上述[1]~[7]中任一项所述的乳化组合物,其中,成分(A)的含量为0.001~10质量%,优选为0.05~3质量%,进一步优选为0.1~2质量%。[8] The emulsified composition according to any one of [1] to [7] above, wherein the content of component (A) is 0.001 to 10% by mass, preferably 0.05 to 3% by mass, more preferably 0.1% by mass ~2% by mass.
[9]如上述[1]~[8]中任一项所述的乳化组合物,其中,成分(B)的含量为0.001~10质量%,优选为0.1~3质量%,进一步优选为0.1~2.5质量%。[9] The emulsified composition according to any one of [1] to [8] above, wherein the content of component (B) is 0.001 to 10% by mass, preferably 0.1 to 3% by mass, more preferably 0.1% by mass ~2.5% by mass.
[10]如上述[1]~[9]中任一项所述的乳化组合物,其中,成分(C)的含量为0.001~10质量%,优选为0.1~5质量%,进一步优选为0.2~3质量%。[10] The emulsified composition according to any one of [1] to [9] above, wherein the content of component (C) is 0.001 to 10% by mass, preferably 0.1 to 5% by mass, more preferably 0.2% by mass ~3% by mass.
[11]如上述[1]~[10]中任一项所述的乳化组合物,其中,成分(D)的换算成酸的含量为0.01~3质量%,优选为0.05~2质量%,进一步优选为0.1~1.5质量%。[11] The emulsified composition according to any one of [1] to [10] above, wherein the content of component (D) in terms of acid is 0.01 to 3% by mass, preferably 0.05 to 2% by mass, More preferably, it is 0.1-1.5 mass %.
[12]如上述[1]~[11]中任一项所述的乳化组合物,其中,成分(E)的含量为0.0025~4质量%,优选为0.01~3质量%,进一步优选为0.03~2质量%。[12] The emulsified composition according to any one of [1] to [11] above, wherein the content of component (E) is 0.0025 to 4% by mass, preferably 0.01 to 3% by mass, more preferably 0.03% by mass ~2% by mass.
[13]如上述[1]~[12]中任一项所述的乳化组合物,其中,成分(A)的含量为0.001~10质量%,成分(B)的含量为0.001~10质量%,成分(C)的含量为0.001~10质量%,成分(D)的换算成酸的含量为0.01~3质量%,成分(E)的含量为0.0025~4质量%。[13] The emulsified composition according to any one of [1] to [12] above, wherein the content of component (A) is 0.001 to 10% by mass, and the content of component (B) is 0.001 to 10% by mass , the content of the component (C) is 0.001 to 10% by mass, the content of the component (D) in terms of acid is 0.01 to 3% by mass, and the content of the component (E) is 0.0025 to 4% by mass.
[14]如上述[1]~[12]中任一项所述的乳化组合物,其中,成分(A)的含量为0.05~3质量%,成分(B)的含量为0.1~3质量%,成分(C)的含量为0.1~5质量%,成分(D)的换算成酸的含量为0.05~2质量%,成分(E)的含量为0.0025~4质量%。[14] The emulsified composition according to any one of [1] to [12] above, wherein the component (A) content is 0.05 to 3% by mass, and the component (B) content is 0.1 to 3% by mass , the content of the component (C) is 0.1 to 5% by mass, the content of the component (D) in terms of acid is 0.05 to 2% by mass, and the content of the component (E) is 0.0025 to 4% by mass.
[15]如上述[1]~[14]中任一项所述的乳化组合物,其中,成分(F)的含量为20~99质量%,优选为40~90质量%。[15] The emulsified composition according to any one of [1] to [14] above, wherein the content of the component (F) is 20 to 99% by mass, preferably 40 to 90% by mass.
[16]如上述[4]~[15]中任一项所述的乳化组合物,其中,成分(G)的含量为0.001~20质量%,优选为0.2~20质量%,进一步优选为2~20质量%,另外优选为0.2~15质量%,进一步优选为2~10质量%。[16] The emulsified composition according to any one of [4] to [15] above, wherein the content of component (G) is 0.001 to 20% by mass, preferably 0.2 to 20% by mass, more preferably 2 ~20% by mass, preferably 0.2 to 15% by mass, more preferably 2 to 10% by mass.
[17]如上述[1]~[16]中任一项所述的乳化组合物,其中,成分(A)为由碳原子数为10~24的直链脂肪酸得到的甘油单脂肪酸酯,优选为选自甘油单棕榈酸酯、甘油单硬脂酸酯以及甘油单山萮酸酯中的1种或者2种以上。[17] The emulsified composition according to any one of [1] to [16] above, wherein the component (A) is a monoglyceride fatty acid ester obtained from a straight-chain fatty acid having 10 to 24 carbon atoms, It is preferably one or two or more selected from glyceryl monopalmitate, glyceryl monostearate, and glyceryl monobehenate.
[18]如上述[1]~[17]中任一项所述的乳化组合物,其中,成分(B)为碳原子数为14~22的高级醇,优选为选自鲸蜡醇、硬脂醇、以及山嵛醇中的1种或者2种以上。[18] The emulsified composition according to any one of the above [1] to [17], wherein component (B) is a higher alcohol having 14 to 22 carbon atoms, preferably selected from cetyl alcohol, hard alcohol, One or more of fatty alcohol and behenyl alcohol.
[19]如上述[1]~[18]中任一项所述的乳化组合物,其中,成分(C)为选自天然型神经酰胺以及假型神经酰胺的神经酰胺,[19] The emulsified composition according to any one of [1] to [18] above, wherein component (C) is a ceramide selected from natural ceramides and pseudo-ceramides,
其中,天然型神经酰胺选自鞘氨醇、二氢鞘氨醇、植物鞘氨醇或者鞘氨二烯醇被酰胺化的神经酰胺1~7型以及它们的N-烷基体,Wherein, the natural ceramides are selected from ceramide types 1-7 of sphingosine, dihydrosphingosine, phytosphingosine or sphingodienol amidated and their N-alkyl forms,
假型神经酰胺由通式(2)所表示,The pseudotyped ceramide is represented by the general formula (2),
(式中,R15表示可以被羟基取代的碳原子数为10~22的直链、支链或者环状的饱和或者不饱和的烃基,或表示氢原子;X9表示氢原子、乙酰基或者甘油基;R16为可以被羟基或者氨基取代的碳原子数为5~22的直链、支链或者环状的饱和或者不饱和的烃基,或者表示在该烃基的ω末端上通过酯键结合有可以被羟基取代的碳原子数为8~22的直链或者支链的饱和或者不饱和的脂肪酸的基团;R17表示氢原子,或者表示可以被羟基、羟基烷氧基、烷氧基或者乙酰氧基取代的总碳原子数为1~30的烷基。)(In the formula, R15 represents a linear, branched or cyclic saturated or unsaturated hydrocarbon group with 10-22 carbon atoms that can be substituted by a hydroxyl group, or represents a hydrogen atom; X9 represents a hydrogen atom, an acetyl group or Glyceryl; R 16 is a straight-chain, branched or cyclic saturated or unsaturated hydrocarbon group with 5-22 carbon atoms that can be substituted by hydroxyl or amino group, or it means that the omega end of the hydrocarbon group is bound by an ester bond There is a group of straight-chain or branched saturated or unsaturated fatty acids with 8 to 22 carbon atoms that can be substituted by hydroxyl; R 17 represents a hydrogen atom, or represents that it can be substituted by hydroxyl, hydroxyalkoxy, or alkoxy Or an alkyl group with a total carbon number of 1 to 30 substituted by an acetoxy group.)
[20]如上述[1]~[19]中任一项所述的乳化组合物,其中,成分(D)选自由碳原子数为12~24的脂肪酸得到的脂肪酸盐、由碳原子数为14~22的脂肪酸得到的脂肪酸酰胺磺酸盐、具有碳原子数为14~22的烷基的聚氧乙烯烷基醚磷酸盐以及由碳原子数为12~22的脂肪酸得到的N-酰基谷氨酸盐中的1种或者2种以上,优选选自由碳原子数为18~22的脂肪酸得到的脂肪酸酰胺磺酸盐、具有碳原子数为18~22的烷基的聚氧乙烯烷基醚磷酸盐以及由碳原子数为18~22的脂肪酸得到的N-酰基谷氨酸盐中的1种或者2种以上,进一步优选选自N-硬脂酰基-N-甲基牛磺酸钠、N-硬脂酰基-L-谷氨酸精氨酸、聚氧乙烯硬脂基醚磷酸钠中的1种或者2种以上。[20] The emulsified composition according to any one of [1] to [19] above, wherein component (D) is selected from fatty acid salts obtained from fatty acids having 12 to 24 carbon atoms, Fatty acid amide sulfonates obtained from fatty acids with 14 to 22 carbon atoms, polyoxyethylene alkyl ether phosphates with alkyl groups with 14 to 22 carbon atoms, and N-acyl groups obtained from fatty acids with 12 to 22 carbon atoms One or more kinds of glutamate, preferably selected from fatty acid amide sulfonates obtained from fatty acids having 18 to 22 carbon atoms, polyoxyethylene alkyl groups having alkyl groups having 18 to 22 carbon atoms One or more of ether phosphates and N-acyl glutamate obtained from fatty acids with 18 to 22 carbon atoms, more preferably selected from sodium N-stearyl-N-methyl taurate , N-stearyl-L-glutamic acid arginine, and one or more of polyoxyethylene stearyl ether sodium phosphate.
[21]如上述[4]~[20]中任一项所述的乳化组合物,其中,成分(G)为选自1,3-丁二醇、异戊二醇、丙二醇、1,3-丙二醇、二丙二醇、二乙二醇单乙基醚、分子量为100~1万的聚丙二醇、分子量为100~1万的聚乙二醇以及环氧乙烷的平均加成摩尔数为4~20的聚氧乙烯二甘油醚中的多元醇。[21] The emulsified composition according to any one of [4] to [20] above, wherein component (G) is selected from 1,3-butanediol, isoprene glycol, propylene glycol, 1,3 - The average added moles of propylene glycol, dipropylene glycol, diethylene glycol monoethyl ether, polypropylene glycol with a molecular weight of 1 million to 10,000, polyethylene glycol with a molecular weight of 1 million to 10,000, and ethylene oxide are 4~ 20 polyols in polyoxyethylene diglyceryl ether.
[22]如上述[1]~[21]中任一项所述的乳化组合物,其中,成分(A)、(B)、(C)以及换算成酸的成分(D)的含量和成分(G)的含量的质量比例((A)+(B)+(C)+(D))/(G)为0.1~20,优选为0.2~16,进一步优选为0.3~4。[22] The emulsified composition according to any one of [1] to [21] above, wherein the contents and components of components (A), (B), and (C) and component (D) in terms of acid The mass ratio ((A)+(B)+(C)+(D))/(G) of the content of (G) is 0.1-20, preferably 0.2-16, more preferably 0.3-4.
[23]如上述[1]~[22]中任一项所述的乳化组合物,其中,所述乳化组合物为水包油型乳化组合物。[23] The emulsified composition according to any one of [1] to [22] above, which is an oil-in-water emulsified composition.
[24]如上述[1]~[23]中任一项所述的乳化组合物在用于涂布于皮肤上使用的用途。[24] Use of the emulsified composition according to any one of the above-mentioned [1] to [23] for coating on the skin.
[25]如上述[1]~[23]中任一项所述的乳化组合物在用于制造皮肤涂布剂中的用途。[25] Use of the emulsified composition according to any one of the above-mentioned [1] to [23] for producing a skin coating agent.
[26]如上述[1]~[23]中任一项所述的乳化组合物的制造方法,其中,包括以下工序:将含有成分(A)、(B)和(C)的第1油相加热混合的工序;接着,添加含有成分(D)的酸型化合物和碱、以及成分(F)的一部分(F1)的第1水相的工序;接着,添加加热的混合其它油性成分的第2油相并搅拌的工序;冷却的工序;然后,进一步边添加作为剩余的成分(F)的(F2)和其它的水溶性成分的第2水相边混合的工序。[26] The method for producing an emulsified composition according to any one of [1] to [23] above, which includes the step of adding the first oil containing components (A), (B) and (C) The process of heating and mixing the phases; then, the process of adding the first aqueous phase containing the acid compound and alkali of the component (D), and a part (F1) of the component (F); 2. The process of stirring the oil phase; the process of cooling; and the process of further mixing while adding (F2) which is the remaining component (F) and the second aqueous phase of other water-soluble components.
[27]如上述[1]~[23]中任一项所述的乳化组合物的制造方法,其中,包括以下工序:将在成分(A)、(B)以及(C)中含有成分(D)的酸型化合物的第1油相加热混合的工序;接着,添加加热的含有碱和成分(F)的一部分(F1)的第1水相并混合的工序;接着,添加加热的混合有其它油性成分的第2油相并搅拌的工序;冷却的工序;然后,进一步边添加含有作为剩余的成分(F)的(F2)和其它的水溶性成分的第2水相边混合的工序。[27] The method for producing an emulsified composition according to any one of [1] to [23] above, which includes the step of adding the component (A), (B) and (C) to the components ( D) A step of heating and mixing the first oil phase of the acid type compound; Next, a step of adding and mixing the heated first aqueous phase containing a part (F1) of the base and the component (F); Next, adding the heated and mixed with A step of stirring the second oil phase of other oily components; a step of cooling; and a step of further mixing while adding (F2) as the remaining component (F) and a second aqueous phase containing other water-soluble components.
[28]如上述[1]~[23]中任一项所述的乳化组合物的制造方法,其中,包括以下工序:将在成分(A)、(B)以及(C)中含有成分(D)的酸型化合物的一部分的第1油相加热混合的工序;接着,添加加热的含有成分(D)的剩余的酸型化合物和碱以及成分(F)的一部分(F1)的第1水相并混合的工序;接着,混合加热的含有其它油性成分的第2油相的工序;冷却的工序;然后,进一步边添加含有作为剩余的成分(F)的(F2)和其它的水溶性成分的第2水相边混合的工序。[28] The method for producing an emulsified composition according to any one of the above [1] to [23], which includes the step of adding (A), (B) and (C) to the components ( D) A process of heating and mixing the first oil phase of a part of the acid compound; then, adding the heated first water containing the remaining acid compound and base of the component (D) and a part (F1) of the component (F) Phase and mixing process; Next, the process of mixing the heated second oil phase containing other oily components; Cooling process; Then, further adding (F2) containing the remaining component (F) and other water-soluble components The process of mixing the second aqueous phase.
实施例Example
实施例1~4以及比较例1~2Embodiment 1~4 and comparative example 1~2
制造表1所示组成的水包油型乳化组合物,评价稳定性以及使用感(无毛糙感、清爽湿润感、无发粘感)。结果一并示于表1。An oil-in-water emulsion composition having the composition shown in Table 1 was produced, and the stability and feeling in use (no rough feeling, refreshing moist feeling, and no sticky feeling) were evaluated. The results are shown in Table 1 together.
(制造方法)(Manufacturing method)
将第1油相的成分(含有成分(A)~(C)的混合成分)在80~90℃下加热混合,在螺旋桨的搅拌下(300rpm),向其中添加加热至80~90℃的第1水相(含有成分(D)和成分(F)中的一部分的水(F1)的水溶液,(F1)水的量是制造后的乳化组合物的45%),接下来,添加加热至80~90℃的第2油相(成分(E)及其它油性成分)。通过用均质机(7000rpm)搅拌之后,在螺旋桨搅拌下(300rpm)冷却至25℃,添加第2水相(作为第1水相的残留成分(F)的(F2)和其它的水溶性成分)。从而得到水包油型乳化组合物。The ingredients of the first oil phase (combined ingredients containing ingredients (A)~(C)) are heated and mixed at 80~90°C, and the second oil heated to 80~90°C is added thereto under the stirring of the propeller (300rpm). 1 water phase (an aqueous solution containing component (D) and part of water (F1) in component (F), the amount of (F1) water is 45% of the emulsified composition after manufacture), and then add and heat to 80 The second oil phase (ingredient (E) and other oily ingredients) at ~90°C. After stirring with a homogenizer (7000rpm), cool to 25°C under propeller stirring (300rpm), and add the second water phase ((F2) as the residual component (F) of the first water phase) and other water-soluble ingredients ). Thus, an oil-in-water emulsion composition was obtained.
(评价方法)(Evaluation method)
(1)稳定性:(1) Stability:
对实施例以及比较例的乳化组合物进行保存加速试验。保存加速试验是循环试验,是在一天中使保存温度在15℃~60℃中变化(15℃~60℃的循环/天),将其进行7天。对保存加速试验后的实施例以及比较例的乳化组合物,在偏光下、通过光学显微镜观察,确认结晶的有无。结晶的有无通过以下的标准进行评价。The accelerated storage test was performed on the emulsified compositions of Examples and Comparative Examples. The accelerated storage test is a cycle test, and the storage temperature is varied in a day from 15°C to 60°C (cycle of 15°C to 60°C/day) for 7 days. The emulsion compositions of Examples and Comparative Examples after the accelerated storage test were observed with an optical microscope under polarized light to confirm the presence or absence of crystals. The presence or absence of crystals was evaluated by the following criteria.
AA:没有观察到结晶。AA: No crystallization was observed.
A:稍微观察到结晶。A: Crystals were slightly observed.
B:观察到小的结晶。B: Small crystals were observed.
C:观察到针状结晶。C: Needle crystals were observed.
(2)使用感(无毛糙感、清爽湿润感、无滑腻感):(2) Feeling in use (no rough feeling, refreshing and moist feeling, no greasy feeling):
专门评价小组成员将0.5~0.6g各乳化组合物用手指一边在脸上滑动一边涂布,按照以下的4个等级的标准进行评价。评价的结果是用3位专门评价小组成员的评价的合计值表示。The panelist applied 0.5 to 0.6 g of each emulsified composition on the face while sliding it with a finger, and evaluated it according to the following four-level criteria. The result of the evaluation is expressed by the total value of the evaluations of the three special evaluation panel members.
“无毛糙感”:从涂布时至刚涂布后的评价。"No rough feeling": evaluation from the time of coating to immediately after coating.
4:没有感觉到毛糙感。4: Roughness is not felt.
3:基本没有感觉到毛糙感。3: Roughness is hardly felt.
2:稍微感觉到毛糙感。2: Slight roughness is felt.
1:毛糙。1: Rough.
“清爽湿润感”:刚涂布后3分钟内的评价。"Refreshing moist feeling": Evaluation within 3 minutes immediately after application.
4:好。4: Good.
3:稍微良好。3: Slightly good.
2:不太好。2: Not so good.
1:不好。1: Not good.
“无滑腻感”:刚涂布后3分钟内的评价。"No slippery feeling": Evaluation within 3 minutes immediately after application.
4:无滑腻感。4: No stickiness.
3:基本无滑腻感。3: Almost no slippery feeling.
2:稍微有滑腻感。2: Slightly slippery.
1:有滑腻感。1: There is a slippery feeling.
[表1][Table 1]
*1:成分(D)为作为酸的含量*1: Component (D) is the acid content
*2:KSG-16(信越化学工业公司制造);(聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷)交联聚合物(25%)和聚二甲基硅氧烷的混合物*2: KSG-16 (manufactured by Shin-Etsu Chemical Co., Ltd.); (Dimethicone/Vinyl Dimethicone) Crosspolymer (25%) and Dimethicone mixture
由表1所示的实施例所得到的组合物通过光学显微镜均没有观察到神经酰胺类的结晶,因此是稳定的,并且通过广角X射线衍射确认为α-凝胶,观察到与α-凝胶相独立的由交联型聚硅氧烷所产生的油滴,并且判断形成层状片层。The compositions obtained by the examples shown in Table 1 were not observed crystallization of ceramides through an optical microscope, so they were stable, and were confirmed as α-gels by wide-angle X-ray diffraction. The gum phase is independent of oil droplets produced by cross-linked polysiloxane, and it is judged to form lamellar sheets.
实施例5~11Embodiment 5~11
与实施例1~4同样制造表2所示组成的水包油型乳化组合物,评价稳定性以及使用感(无毛糙感、清爽湿润感、无滑腻感)。结果一并示于表2。Oil-in-water emulsion compositions with the compositions shown in Table 2 were produced in the same manner as in Examples 1 to 4, and the stability and use feeling (no rough feeling, refreshing moist feeling, and non-greasy feeling) were evaluated. The results are shown in Table 2 together.
另外,在实施例中得到的组合物通过光学显微镜均没有观察到或者基本没有观察到神经酰胺类的结晶,因而是稳定的,并且通过广角X射线衍射确认为α-凝胶。另外,观察到α-凝胶和由交联型聚硅氧烷所产生的油滴,判断为形成层状片层。In addition, the compositions obtained in Examples were stable because no or almost no crystals of ceramides were observed by an optical microscope, and were confirmed to be α-gels by wide-angle X-ray diffraction. In addition, α-gel and oil droplets generated from the crosslinked polysiloxane were observed, and it was judged that a lamellar sheet was formed.
[表2][Table 2]
*1:成分(D)为作为酸的含量*1: Component (D) is the acid content
*2:KSG-16(信越化学工业公司制造);(聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷)交联聚合物(25%)和聚二甲基硅氧烷的混合物*2: KSG-16 (manufactured by Shin-Etsu Chemical Co., Ltd.); (Dimethicone/Vinyl Dimethicone) Crosspolymer (25%) and Dimethicone mixture
实施例12~25Example 12~25
与实施例1~4同样制造表3所示组成的水包油型乳化组合物,评价稳定性以及使用感(无毛糙感、清爽湿润感、无滑腻感)。结果一并示于表3。An oil-in-water emulsion composition having the composition shown in Table 3 was produced in the same manner as in Examples 1 to 4, and the stability and use feeling (no rough feeling, refreshing moist feeling, and no slippery feeling) were evaluated. The results are shown in Table 3 together.
并且,由实施例得到的组合物通过光学显微镜均基本没有观察到神经酰胺的结晶,因而是稳定的,并且通过广角X射线衍射确认为α-凝胶。另外,观察到α-凝胶和由交联型聚硅氧烷产生的油滴,判断为形成层状片层。In addition, the compositions obtained in the examples were all stable because almost no crystals of ceramide were observed by an optical microscope, and were confirmed to be α-gels by wide-angle X-ray diffraction. In addition, α-gel and oil droplets derived from the crosslinked polysiloxane were observed, and it was judged that lamellar sheets were formed.
[表3][table 3]
*1:成分(D)为作为酸的含量*1: Component (D) is the acid content
*2:KSG-16(信越化学工业公司制造);(聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷)交联聚合物(25%)和聚二甲基硅氧烷的混合物*2: KSG-16 (manufactured by Shin-Etsu Chemical Co., Ltd.); (Dimethicone/Vinyl Dimethicone) Crosspolymer (25%) and Dimethicone mixture
试验例1Test example 1
关于实施例7的乳化组合物,显示通过光学显微镜用普通光观察得到的照片(图1(b))和施加偏光观察得到的照片(图1(a))。Regarding the emulsified composition of Example 7, a photograph ( FIG. 1( b )) observed with ordinary light by an optical microscope and a photograph observed with polarized light ( FIG. 1( a )) are shown.
如图1(b)所示,观察相对大的油滴,其为含有成分(E)的交联型聚硅氧烷的油滴。连续相为水相,相对小的油滴具有球状片层结构,在如图1(a)那样加偏光的照片中可见为白色。在看上去是白色的小油滴为球状片层的情况下,放大照片可以如图1(a1)那样确认。另外,可以通过广角X射线衍射(Bragg角21~23°)确认α-凝胶的结构。在层状片层形成的情况下,通过小角X射线衍射(Bragg角0.3~5°),可以在Bragg角为1:2:3:4的比处观察到峰。本发明的乳化组合物是使用离心分离机浓缩,再用小角X射线衍射测定。由以上可知,本发明的组合物的连续相为水相,通过含有(E)交联型聚硅氧烷的油滴和含有球状片层和层状片层的α-凝胶,可以使稳定性和使用感良好。As shown in FIG. 1( b ), relatively large oil droplets were observed, which were oil droplets of the crosslinked polysiloxane containing component (E). The continuous phase is the water phase, and the relatively small oil droplets have a spherical sheet structure, which can be seen as white in the polarized photo as shown in Figure 1(a). When the small oil droplets that appear to be white are spherical sheets, they can be confirmed as shown in Fig. 1(a1) in the enlarged photograph. In addition, the structure of α-gel can be confirmed by wide-angle X-ray diffraction (Bragg angle 21~23°). In the case of lamellar sheet formation, peaks can be observed at the Bragg angle ratio of 1:2:3:4 by small angle X-ray diffraction (Bragg angle 0.3~5°). The emulsified composition of the present invention is concentrated by using a centrifugal separator, and then measured by small-angle X-ray diffraction. As can be seen from the above, the continuous phase of the composition of the present invention is an aqueous phase, which can stabilize Good sex and usability.
实施例7以及比较例3Example 7 and Comparative Example 3
和实施例1~4同样制造表4所示组成的水包油型乳化组合物,评价稳定性以及使用感(无毛糙感、清爽湿润感、无滑腻感)。另外,评价保湿的持续感。结果一并示于表4。另外,实施例7为与上述表2所记载的物质同样的物质。An oil-in-water emulsion composition having the composition shown in Table 4 was produced in the same manner as in Examples 1 to 4, and the stability and use feeling (no rough feeling, refreshing moist feeling, and non-greasy feeling) were evaluated. In addition, the lasting feeling of moisturizing was evaluated. The results are shown in Table 4 together. In addition, Example 7 is the same substance as that described in Table 2 above.
(保湿的持续感的评价方法)(Evaluation method for the lasting feeling of moisturizing)
3位专门评价小组成员对将0.5~0.6g各乳化组合物涂布于脸上1小时之后的“清爽湿润感”按照以下的标准进行评价。结果用3位评价的合计来评价。Three panelists evaluated the "refreshing moist feeling" 1 hour after applying 0.5 to 0.6 g of each emulsion composition to the face according to the following criteria. The results were evaluated by the total of three evaluations.
4:清爽湿润。4: Refreshing and moist.
3:稍微清爽湿润。3: slightly refreshing and moist.
2:有点不清爽湿润。2: Slightly not refreshing and moist.
1:不清爽湿润。1: Not refreshing and moist.
[表4][Table 4]
*1:成分(D)为作为酸的含量*1: Component (D) is the acid content
*2:KSG-16(信越化学工业公司制造);(聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷)交联聚合物(25%)和聚二甲基硅氧烷的混合物*2: KSG-16 (manufactured by Shin-Etsu Chemical Co., Ltd.); (Dimethicone/Vinyl Dimethicone) Crosspolymer (25%) and Dimethicone mixture
实施例26、27Example 26, 27
与实施例1~4同样制造表5所示组成的水包油型乳化组合物。得到的组合物均通过广角X射线衍射确认为α-凝胶。另外,观察到α-凝胶和由交联型聚硅氧烷形成的油滴。另外,抑制毛糙感,且清爽湿润感良好,也没有感觉到滑腻感。The oil-in-water emulsion composition of the composition shown in Table 5 was manufactured similarly to Examples 1-4. The obtained compositions were all confirmed to be α-gels by wide-angle X-ray diffraction. In addition, α-gel and oil droplets formed from cross-linked polysiloxane were observed. In addition, roughness was suppressed, and the refreshing moist feeling was good, and no slippery feeling was felt.
[表5][table 5]
*1:成分(D)为作为酸的含量*1: Component (D) is the acid content
*2:KSG-16(信越化学工业公司制造);(聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷)交联聚合物(25%)和聚二甲基硅氧烷的混合物*2: KSG-16 (manufactured by Shin-Etsu Chemical Co., Ltd.); (Dimethicone/Vinyl Dimethicone) Crosspolymer (25%) and Dimethicone mixture
实施例28、29、30Example 28, 29, 30
与实施例1~4同样制造如表6所示组成的水包油型乳化组合物。得到的组合物均通过广角X射线衍射确认为α-凝胶。另外,观察到α-凝胶和由交联型聚硅氧烷形成的油滴。另外,抑制毛糙感,且清爽湿润感良好,也没有感觉到滑腻感。An oil-in-water emulsion composition having the composition shown in Table 6 was produced in the same manner as in Examples 1 to 4. The obtained compositions were all confirmed to be α-gels by wide-angle X-ray diffraction. In addition, α-gel and oil droplets formed from cross-linked polysiloxane were observed. In addition, roughness was suppressed, and the refreshing moist feeling was good, and no slippery feeling was felt.
[表6][Table 6]
*1:成分(D)为作为酸的含量*1: Component (D) is the acid content
*2:KSG-16(信越化学工业公司制造);(聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷)交联聚合物(25%)和聚二甲基硅氧烷的混合物*2: KSG-16 (manufactured by Shin-Etsu Chemical Co., Ltd.); (Dimethicone/Vinyl Dimethicone) Crosspolymer (25%) and Dimethicone mixture
*3:KSG-18A(信越化学工业公司制造);(聚二甲基硅氧烷/苯基乙烯基聚二甲基硅氧烷)交联聚合物(15%)和二苯基硅氧烷苯基三甲基聚硅氧烷的混合物*3: KSG-18A (manufactured by Shin-Etsu Chemical Co., Ltd.); (dimethicone/phenylvinyl dimethicone) crosspolymer (15%) and diphenylsiloxane Mixture of phenyl trimethicone
实施例31、32、33Example 31, 32, 33
与实施例1~4同样制造如表7所示组成的水包油型乳化组合物。得到的组合物均通过广角X射线衍射确认为α-凝胶。另外,观察到α-凝胶和由交联型聚硅氧烷形成的油滴。另外,抑制毛糙感,且清爽湿润感良好,也没有感觉到滑腻感。The oil-in-water emulsion composition of the composition shown in Table 7 was manufactured similarly to Examples 1-4. The obtained compositions were all confirmed to be α-gels by wide-angle X-ray diffraction. In addition, α-gel and oil droplets formed from cross-linked polysiloxane were observed. In addition, roughness was suppressed, and the refreshing moist feeling was good, and no slippery feeling was felt.
[表7][Table 7]
*2:KSG-16(信越化学工业公司制造);(聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷)交联聚合物(25%)和聚二甲基硅氧烷的混合物*2: KSG-16 (manufactured by Shin-Etsu Chemical Co., Ltd.); (Dimethicone/Vinyl Dimethicone) Crosspolymer (25%) and Dimethicone mixture
Claims (16)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011174389 | 2011-08-09 | ||
| JP2011-174389 | 2011-08-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102949303A true CN102949303A (en) | 2013-03-06 |
| CN102949303B CN102949303B (en) | 2016-05-25 |
Family
ID=47759064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210281749.9A Active CN102949303B (en) | 2011-08-09 | 2012-08-09 | emulsified composition |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP5961071B2 (en) |
| CN (1) | CN102949303B (en) |
| TW (1) | TWI543772B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112261933A (en) * | 2018-06-12 | 2021-01-22 | 花王株式会社 | W/O type emulsified composition |
| CN116804153A (en) * | 2023-08-24 | 2023-09-26 | 上海柯珑清洁技术有限公司 | Acrylamide surfactant composition and preparation method thereof |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015052754A1 (en) * | 2013-10-07 | 2015-04-16 | 花王株式会社 | Cosmetic composition |
| JP2016088866A (en) * | 2014-10-31 | 2016-05-23 | 株式会社コスモステクニカルセンター | CONTAMINANT PERMEATION PREVENTIVE FORMING α GEL STRUCTURE, AND CONTAMINANT PERMEATION-PREVENTING COSMETIC OR CONTAMINANT PERMEATION-PREVENTING SKIN EXTERNAL PREPARATION INCLUDING THE SAME |
| JP2016088930A (en) * | 2014-10-31 | 2016-05-23 | 日光ケミカルズ株式会社 | FINE WRINKLE IMPROVER FORMING α GEL STRUCTURE, AND FINE WRINKLE IMPROVING COSMETIC OR FINE WRINKLE IMPROVING SKIN EXTERNAL PREPARATION INCLUDING THE SAME |
| JP2016088872A (en) * | 2014-10-31 | 2016-05-23 | 株式会社コスモステクニカルセンター | TEXTURE IMPROVING AGENT IN WHICH α GEL-STRUCTURE IS FORMED, AND COSMETIC OR EXTERNAL SKIN PREPARATION FOR IMPROVING TEXTURE CONTAINING THE SAME |
| JP6624814B2 (en) * | 2015-05-29 | 2019-12-25 | 花王株式会社 | Skin cosmetics |
| EP3808330B1 (en) * | 2018-06-12 | 2025-08-27 | Kao Corporation | W/o emulsion composition containing ceramides |
| JP7186520B2 (en) * | 2018-06-12 | 2022-12-09 | 花王株式会社 | W/O emulsion composition |
| JP7725186B2 (en) * | 2018-06-12 | 2025-08-19 | 花王株式会社 | W/O type emulsion composition |
| JP2020200283A (en) * | 2019-06-11 | 2020-12-17 | 花王株式会社 | Sheet-like cosmetics |
| JP2022167254A (en) * | 2021-04-23 | 2022-11-04 | クラシエホームプロダクツ株式会社 | aftershave agent |
| EP4635473A1 (en) * | 2022-12-14 | 2025-10-22 | Kao Corporation | Oil-in-water emulsion composition |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1533267A (en) * | 2000-07-10 | 2004-09-29 | cosmetic composition | |
| JP2007022997A (en) * | 2005-07-21 | 2007-02-01 | Kao Corp | Emulsified composition |
| WO2011004589A1 (en) * | 2009-07-06 | 2011-01-13 | 花王株式会社 | Emulsified composition |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000063234A (en) * | 1998-08-19 | 2000-02-29 | Kose Corp | Oil-in-water type cosmetic |
| JP3854522B2 (en) * | 2002-03-25 | 2006-12-06 | 株式会社コーセー | Makeup cosmetics |
| EP1415645B1 (en) * | 2002-10-29 | 2007-10-03 | L'oreal | Composition in the form of an oil-in-water emulsion and its cosmetic uses |
| JP4040527B2 (en) * | 2003-05-09 | 2008-01-30 | 高砂香料工業株式会社 | Lipid composition and external preparation for skin containing the same |
| JP2006219424A (en) * | 2005-02-10 | 2006-08-24 | Kao Corp | Skin cosmetics |
| JP2008044901A (en) * | 2006-08-18 | 2008-02-28 | Kose Corp | Oil-in-water type makeup cosmetic |
| JP5214872B2 (en) * | 2006-11-13 | 2013-06-19 | 株式会社コーセー | Vesicle composition and external preparation for skin containing the same |
| BRPI0719547B1 (en) * | 2006-12-14 | 2015-06-30 | Pola Chem Ind Inc | Preparation for external use skin |
-
2012
- 2012-08-08 JP JP2012176229A patent/JP5961071B2/en active Active
- 2012-08-09 CN CN201210281749.9A patent/CN102949303B/en active Active
- 2012-08-09 TW TW101128819A patent/TWI543772B/en active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1533267A (en) * | 2000-07-10 | 2004-09-29 | cosmetic composition | |
| JP2007022997A (en) * | 2005-07-21 | 2007-02-01 | Kao Corp | Emulsified composition |
| WO2011004589A1 (en) * | 2009-07-06 | 2011-01-13 | 花王株式会社 | Emulsified composition |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112261933A (en) * | 2018-06-12 | 2021-01-22 | 花王株式会社 | W/O type emulsified composition |
| CN112261933B (en) * | 2018-06-12 | 2023-09-08 | 花王株式会社 | W/O type emulsified composition |
| CN116804153A (en) * | 2023-08-24 | 2023-09-26 | 上海柯珑清洁技术有限公司 | Acrylamide surfactant composition and preparation method thereof |
| CN116804153B (en) * | 2023-08-24 | 2023-11-21 | 上海柯珑清洁技术有限公司 | Acrylamide surfactant composition and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| TWI543772B (en) | 2016-08-01 |
| JP2013053145A (en) | 2013-03-21 |
| TW201311281A (en) | 2013-03-16 |
| JP5961071B2 (en) | 2016-08-02 |
| CN102949303B (en) | 2016-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102949303B (en) | emulsified composition | |
| CN103732206B (en) | emulsified composition | |
| CN103998018B (en) | Oil-in-water emulsion composition | |
| CN103445975B (en) | Emulsification cosmetic composition | |
| CN111615379A (en) | Cosmetic composition comprising particles containing high content of ceramide and method for producing the same | |
| CN109843250B (en) | Self-foaming cosmetic composition and manufacturing method thereof | |
| JP6588568B2 (en) | Composition containing bicell structure | |
| US20190282485A1 (en) | Water-in-oil emulsion cosmetic | |
| CN101600413A (en) | Water-based skin care composition containing polyhydrocarbyl silsesquioxane powder emulsion and preparation method thereof | |
| CN102946850A (en) | Skin improving dermo-cosmetics | |
| JP7324278B2 (en) | Composition containing ceramides and isobutyl oleate | |
| CN102727392A (en) | Emulsified composition | |
| CN104812363A (en) | emulsifying cosmetics | |
| WO2009063016A1 (en) | Topical composition | |
| KR101370328B1 (en) | Immproved feeling and Hydrating effect Water-in-silicone and Silicone-in-water emulsion type using the poly-ionic complex in oil soluble ingredient | |
| KR101070819B1 (en) | Silicone Heavy Water and Underwater Silicone Emulsifying Cosmetic Composition Using Poly Ion Composite | |
| US20140018444A1 (en) | Water-In-Oil Emulsified Cosmetic | |
| JP6423701B2 (en) | Cosmetics | |
| JP6804420B2 (en) | Hair cosmetics | |
| EP2990025B1 (en) | Aqueous composition | |
| JP6936076B2 (en) | Oil-in-water emulsified composition | |
| JPH11263721A (en) | Oil-in-water type gommage (peeling) cosmetic | |
| JP6747763B2 (en) | Emulsified cosmetics | |
| JP5777859B2 (en) | Emulsified composition | |
| WO2019188119A1 (en) | Hair cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |